2019
DOI: 10.1088/1361-6560/ab4e51
|View full text |Cite
|
Sign up to set email alerts
|

Method for a motion model based automated 4D dose calculation

Abstract: The Vero system can treat intra-fractionally moving tumors with gimbaled dynamic tumor tracking (DTT) by rotating the treatment beam so that it follows the motion of the tumor. However, the changes in the beam geometry and the constant breathing motion of the patient influence the dose applied to the patient. This study aims to perform a full 4D dose reconstruction for thirteen patients treated with DTT at the Vero system at the Universitätsklinikum Erlangen and investigates the temporal resolution required to… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 43 publications
0
2
0
Order By: Relevance
“…However, it also has a limited temporal resolution that is dependent on the amount of phases in the 4DCT. It has been shown that accumulating dose distributions with a temporal resolution of 500 ms is adequate for an accurate dose reconstruction 21 . Therefore, if a respiratory cycle has a period of five seconds a ten‐phase 4DCT would provide this resolution.…”
Section: Discussionmentioning
confidence: 99%
“…However, it also has a limited temporal resolution that is dependent on the amount of phases in the 4DCT. It has been shown that accumulating dose distributions with a temporal resolution of 500 ms is adequate for an accurate dose reconstruction 21 . Therefore, if a respiratory cycle has a period of five seconds a ten‐phase 4DCT would provide this resolution.…”
Section: Discussionmentioning
confidence: 99%
“…Intra-fraction motion monitoring, a requirement for the implementation of RRMM, represents a substantial challenge in itself. Other challenges include additional hardware cost, workload and daily treatment time, the need for different QA procedures [29] , [30] , [31] and appropriate staff and patient training. Though RRMM can be considered standard-of-care in some tumour sites (e.g.…”
mentioning
confidence: 99%